Acetylsalicylic acid Unknown Status Phase 2 Trials for Coronary Arteriosclerosis

IndicationsStatusPurposePhase
Unknown StatusNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT01466452Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery